T. Rowe Price Associates
ATOS icon

T. Rowe Price Associates’s Atossa Therapeutics ATOS Stock Holding History

T. Rowe Price Associates’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,413
Closed -$35K – 3067
2025
Q1 		$35K Hold
3,413
– – ﹤0.01% 2967
2024
Q4 		$49K Buy
3,413
+695
+26% +$13.6K ﹤0.01% 2943
2024
Q3 		$62K Hold
2,718
– – ﹤0.01% 2902
2024
Q2 		$0 Buy
+2,718
New +$60.1K ﹤0.01% 2931
2022
Q4 		– Sell
-2,293
Closed -$29K – 2938
2022
Q3 		$29K Hold
2,293
– – ﹤0.01% 2890
2022
Q2 		$37K Sell
2,293
-683
-23% -$10.8K ﹤0.01% 2893
2022
Q1 		$56K Buy
2,976
+1,320
+80% +$26.8K ﹤0.01% 2913
2021
Q4 		$40K Sell
1,656
-180
-10% -$6.59K ﹤0.01% 2934
2021
Q3 		$90K Buy
1,836
+180
+11% +$10.5K ﹤0.01% 2860
2021
Q2 		$157K Buy
+1,656
New +$87.7K ﹤0.01% 2772

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return